Leflunomide-associated Progressive Multifocal Leukoencephalopathy

Arch Neurol. 2008 Nov;65(11):1538-9. doi: 10.1001/archneur.65.11.1538.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid / drug therapy
  • Biopsy
  • Brain / pathology
  • Cytarabine / administration & dosage
  • Cytarabine / therapeutic use
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Injections, Intravenous
  • Isoxazoles / adverse effects*
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Leukoencephalopathy, Progressive Multifocal / complications
  • Leukoencephalopathy, Progressive Multifocal / diagnosis*
  • Leukoencephalopathy, Progressive Multifocal / drug therapy
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Seizures / etiology
  • Staining and Labeling

Substances

  • Immunosuppressive Agents
  • Isoxazoles
  • Cytarabine
  • Leflunomide